Part, Chapter, Paragraph
1 I, 2. 10. 4| although predominantly during prescription and administration. Prescription
2 I, 2. 10. 4| prescription and administration. Prescription and administration are most
3 I, 2. 10. 4| While about half of the prescription errors are intercepted by
4 I, 2. 10. 4| intercepted.~ ~Automating the prescription and administration processes
5 I, 2. 10. 4| point-of-care, electronic prescription systems and robotic dispensing
6 I, 2. 10. 4| implementation of an electronic prescription process and automatic product
7 II, 5. 5. 3| patterns and respective prescription data do not reflect the
8 II, 5. 5. 3| of many qualifications. Prescription data from Germany from the
9 II, 5. 5. 3| CATIE, CUtLASS or EUFEST.~Prescription antipsychotics vary widely
10 II, 5. 5. 3| available. Regarding the prescription of atypical antipsychotics
11 II, 5. 5. 3| 3.5).~Figure 5.5.3.2.5: Prescription of antipsychotics in the
12 II, 5. 7. 5| estimates for any creatinine prescription in order to improve CKD
13 II, 6. 4. 5| substances are available by prescription only in human and veterinary
14 II, 9. 1. 2| and lactation: handbook of prescription drugs and comparative risk
15 II, 9. 3. 1| urological surgical and many prescription and recreational drugs implicated.
16 II, 9. 4. 3| nutritional aspects, careful prescription of psychotropic drugs and
17 II, 9. 5. 3| administration of multiple prescription medication. Women also more
18 III, 10. 2. 1| hospitalisation, ambulatory care, prescription drugs, home health care
19 III, 10. 2. 1| varenicline. They are both prescription drugs approved by national
20 III, 10. 2. 1| illicitly acquired/used prescription opioid medications). Other
21 IV, 11. 1. 3| schedules and introducing prescription drug budgets (e.g. in Germany).~ ~
22 IV, 11. 1. 5| the US, fatalities from prescription errors were found to have
23 IV, 11. 3. 2| expenditure include both prescription and over-the-counter drugs,
24 IV, 11. 3. 2| changes to a physician’s prescription, such as substituting a
25 IV, 11. 3. 2| European countries to global prescription drug market by value (2006)~ ~
26 IV, 11. 3. 2| market in the world with prescription drug sales of $181.8bn in
27 IV, 11. 6. 2| literature shows cost sharing for prescription drugs leads to worse health
28 IV, 11. 6. 2| Belgium (Thomson et al, 2003). Prescription drugs may have cost sharing
29 IV, 11. 6. 2| must pay the full cost of prescription drugs up to an out-of-pocket
30 IV, 11. 6. 5| review of cost sharing for prescription drugs: implications for
31 IV, 12. 2 | varenicline. They are both prescription drugs approved by national
32 IV, 12. 10 | medical card holders on prescription (April 2001)~ ~National
